Literature DB >> 824141

Antibody-dependent human lymphocytotoxicity: a micro assay system.

W P Zeijlemaker, M T Roos, P T Schellekens, V P Eijsvoogel.   

Abstract

A micro assay system is described for measuring antibody-dependent lymphocytotoxicity with human effector cells. The target cells were mouse mastocytoma cells sensitized with rabbit antibody. The tests were performed in microtiter plates, each well containing 5 x 10(3) 51Cr-labeled target cells, together with varying numbers of effector cells. Whereas highly purified lymphocyte suspensions induced lysis, purified monocyte and granulocyte suspensions had virtually no effect. In parallel experiments it was shown that the latter cell suspensions were very active in lysing sensitized human erythrocytes, which in turn were not lysed by purified lymphocytes. Finally, it was shown that the lytic capacity of lymphocytes was not affected by preservation of the cells at liquid nitrogen temperature. It is concluded that the system described can be used for the clinical analysis of antibody-dependent lymphocytotoxicity in lymphocyte suspensions.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 824141     DOI: 10.1002/eji.1830050815

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Complex arming in antibody-dependent cell-mediated cytotoxicity: ultrastructural studies of the interaction between human effector cells armed with aggregated anti-DNP antibody and DNP-coated erythrocytes.

Authors:  P L Penfold; L C Walker; I M Roitt
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

2.  Mechanisms of corticosteroid action on lymphocyte subpopulations. III. Differential effects of dexamethasone administration on subpopulations of effector cells mediating cellular cytotoxicity in man.

Authors:  J E Parrillo; A S Fauci
Journal:  Clin Exp Immunol       Date:  1978-01       Impact factor: 4.330

3.  ADCC mediated by non-adherent mononuclear and polymorphonuclear cells of the guinea-pig.

Authors:  S J Hopkins; M M Dale
Journal:  Immunology       Date:  1980-08       Impact factor: 7.397

4.  Characteristics of complexes for arming and inhibiting effector cells for antibody-dependent cell-mediated cytotoxicity.

Authors:  L Walker; F C Hay; I M Roitt
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

5.  Comparison of the relative cytotoxic effector cell capabilities and the proportions of cells bearing various surface markers in human tonsil and peripheral blood mononuclear cells.

Authors:  G W Hunninghake; B F Haynes; J E Parrillo; A S Fauci
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

6.  Behaviour of effector cells, synovial fluids, and sera from rheumatoid arthritis patients in antibody-dependent cell-mediated cytotoxicity.

Authors:  L A Cooke; F C Hay; R Perumal
Journal:  Ann Rheum Dis       Date:  1979-06       Impact factor: 19.103

7.  Studies of human natural killer cells. III. Neutropenia associated with unusual characteristics of antibody-dependent and natural killer cell-mediated cytotoxicity.

Authors:  H F Pross; J Pater; I Dwosh; A Giles; L A Gallinger; P Rubin; W E Corbett; P Galbraith; M G Baines
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

8.  Evaluation of the immunosuppressive effects of cyclophosphamide in patients with multiple sclerosis.

Authors:  R J ten Berge; H K van Walbeek; P T Schellekens
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

9.  Eosinophil-mediated injury to lung parenchymal cells and interstitial matrix. A possible role for eosinophils in chronic inflammatory disorders of the lower respiratory tract.

Authors:  W B Davis; G A Fells; X H Sun; J E Gadek; A Venet; R G Crystal
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

10.  Severe acquired immunodeficiency in European homosexual men.

Authors:  J Gerstoft; A Malchow-Møller; I Bygbjerg; E Dickmeiss; C Enk; P Halberg; S Haahr; M Jacobsen; K Jensen; J Mejer; J O Nielsen; H K Thomsen; J Søndergaard; I Lorenzen
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.